Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)
137.80 +0.76 (+0.55%) 11:39 ET [NASDAQ]
137.76 x 480 137.81 x 530
Realtime by (Cboe BZX)
137.76 x 480 137.81 x 530
Realtime 136.99 -0.05 (-0.04%) 09:29 ET
Quote Overview for Thu, Feb 27th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
136.79
Day High
138.42
Open 136.95
Previous Close 137.04 137.04
Volume 574,437 574,437
Avg Vol 1,242,377 1,242,377
Stochastic %K 50.97% 50.97%
Weighted Alpha -1.57 -1.57
5-Day Change -1.58 (-1.13%) -1.58 (-1.13%)
52-Week Range 123.60 - 150.57 123.60 - 150.57
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 6,475,139,600
  • Shares Outstanding, K 47,250
  • 60-Month Beta 0.84
  • Price/Earnings ttm 15.68
  • Annual Dividend & Yield 0.39 (0.28%)
  • Most Recent Dividend 0.062 on 12/17/24
  • Management Fee 0.44%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 20.74% ( -0.33%)
  • Historical Volatility 16.88%
  • IV Percentile 78%
  • IV Rank 32.01%
  • IV High 33.78% on 08/05/24
  • IV Low 14.59% on 07/10/24
  • Put/Call Vol Ratio 6.43
  • Today's Volume 981
  • Volume Avg (30-Day) 5,203
  • Put/Call OI Ratio 1.76
  • Today's Open Interest 126,600
  • Open Int (30-Day) 122,278

Price Performance

See More
Period Period Low Period High Performance
1-Month
133.04 +3.62%
on 02/12/25
Period Open: 138.37
142.80 -3.47%
on 02/06/25
-0.52 (-0.38%)
since 01/27/25
3-Month
129.61 +6.36%
on 12/19/24
Period Open: 141.59
142.84 -3.49%
on 12/09/24
-3.74 (-2.64%)
since 11/27/24
52-Week
123.60 +11.53%
on 04/19/24
Period Open: 140.89
150.57 -8.44%
on 09/19/24
-3.04 (-2.16%)
since 02/27/24

Most Recent Stories

More News
Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move?

Early-stage data from the company's gene therapy candidate SGT-003 for Duchenne muscular dystrophy (DMD) showed encouraging results.

SLDB : 5.82 (+10.02%)
VXF : 188.86 (+0.35%)
IBB : 137.80 (+0.55%)
VTI : 293.14 (+0.03%)
IWM : 215.58 (-0.05%)
Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Bio-Techne's underperformance relative to the broader market over the past year, Wall Street analysts remain bullish on the stock's prospects.

TECH : 62.58 (-2.45%)
$SPX : 5,968.96 (+0.22%)
IBB : 137.80 (+0.55%)
IBB : 137.80 (+0.55%)
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing

The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.

TCAF : 33.69 (-0.09%)
ASND : 153.76 (+0.75%)
IBB : 137.80 (+0.55%)
HRTS : 30.73 (+0.66%)
Tempus AI Stock Swings Wildly As Earnings Near, Retail’s Cautiously Optimistic After Insider Sales

The company has gained a lot of attention since launching an AI-enabled personal health app last month.

ARKG : 25.82 (+0.74%)
IBB : 137.80 (+0.55%)
VTI : 293.14 (+0.03%)
TEM : 60.00 (-3.63%)
Intellia Stock Dips After Morgan Stanley Downgrade, Retail Sentiment Weakens

The brokerage pointed to the company’s recent discontinuation of its NTLA-3001 program for alpha-1 antitrypsin deficiency-associated lung disease, reducing near-term growth prospects.

ARKG : 25.82 (+0.74%)
IBB : 137.80 (+0.55%)
XBI : 89.38 (+1.28%)
NTLA : 11.63 (+7.69%)
There May Still Be Time to Get in on These 3 Trending Biotechs

Biotech firms as a group declined slightly in the last year amid a tough external environment, but these three companies could grow in 2025.

AVDL : 7.89 (-1.00%)
SANA : 2.78 (+6.51%)
IBB : 137.80 (+0.55%)
ADMA : 16.05 (+1.71%)
We Asked Retail If Novavax Stock Is A Buy At Current Levels: Nearly 70% Think It's Undervalued

Message volume on Stocktwits has surged by over 1,200% since the beginning of the year, reflecting growing interest.

IBB : 137.80 (+0.55%)
NVAX : 7.80 (+6.56%)
XBI : 89.38 (+1.28%)
IWM : 215.58 (-0.05%)
SNY : 54.48 (-0.86%)
Precigen Completes Regulatory Filing For Approval Of Gene Therapy To Treat Respiratory Papillomatosis: Retail Sentiment Surges Amid Stock Rally

Recurrent respiratory papillomatosis is a rare condition when benign tumors called papillomas grow in the respiratory tract, most commonly in the larynx.

IWC : 123.52 (+0.15%)
PGEN : 1.8650 (+3.04%)
IBB : 137.80 (+0.55%)
How Is Bio-Techne’s Stock Performance Compared to Other Biotechnology Stocks?

Bio-Techne has underperformed the biotechnology industry over the past year, but analysts are highly optimistic about the stock’s prospects.

TECH : 62.58 (-2.45%)
IBB : 137.80 (+0.55%)
BIO : 273.20 (-1.08%)
Altimmune’s Nasdaq Biotech Index Addition Fuels Retail Enthusiasm, Stock Rebounds

The NBI serves as the basis for the iShares NASDAQ Biotechnology Index Fund and is reevaluated annually.

IBB : 137.80 (+0.55%)
ALT : 6.42 (+8.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

3rd Resistance Point 140.56
2nd Resistance Point 139.68
1st Resistance Point 138.36
Last Price 137.80
1st Support Level 136.16
2nd Support Level 135.28
3rd Support Level 133.96

See More

52-Week High 150.57
Fibonacci 61.8% 140.26
Last Price 137.80
Fibonacci 50% 137.08
Fibonacci 38.2% 133.90
52-Week Low 123.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements